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Summary.-Tumour-cell growth in lung nodules after i.v. transfer to sublethally
irradiated mice has been followed after adoptive transfer of different populations of
lymphoid cells. Spleen cells deliberately immunized in vitro and in vivo against
stimulator cells bearing embryo-associated antigens and which are cytostatic in
vitro for targets bearing such antigens, can diminish the number of lung nodules
found after i.v. transfer. In contrast, cytotoxic (in vitro) spleen cells, while capable of
diminishing local (s.c.) growth of tumour cells, cannot control systemic tumour
growth. Within a given solid tumour mass, the subpopulations resistant to cytostatic
effector cells in vitro are the ones most likely to produce lung colonies after adoptive
transfer in vivo, though they show no more local (s.c.) growth than to cytostatic-
sensitive cells in vivo.
EARLIER WORK from this and other
laboratories has established that embryo-
immunized lymphocyte populations can
confer protection (growth retardation)
against s.c. implants of tumour cells in
syngeneic hosts, and can decrease lung
metastases in a rat hepatoma system
(Gorczynski & MacRae, unpublished and
1981; Baldwin et al., 1974). There is
evidence in the literature that the state of
macrophage activation, and the infiltra-
tion of such cells into the tumour mass, is
correlated with metastases in the autolo-
gous host (Hibbs, 1973; Eccles & Alex-
ander, 1974). In contrast, our studies have
suggested that lymphoid cells, the activity
of which can also be assessed in a 48h in
vitro microcytotoxicity test, are the pre-
dominant effector-cell populations in regu-
lating local (s.c.) growth of tumour cells
(Gorezynski & MacRae, unpublished). An
alternative cytotasis assay, also per-
formed over a 48h culture period, detects,
in addition to cytotoxic lymphocytes,
other effector-cell populations (adherent,
non-0-bearing) which also appear after
* To w}liom all corres;pon(lence silioul( be a(ldressed.
deliberate exposure (during pregnancy or
growth of tumours bearing neoantigens)
of spleen cells to embryo-associated anti-
gens in vitro or in vivo (Gorczynski &
MacRae, 1981).
We have analysed the kinetics of
appearance and loss of cytostatic effector-
cell activity in the spleen of tumour-
bearing and tumour-resected mice, and
the heterogeneity ofsensitivity oftumour-
cell subpopulations (within one solid
tumour mass) to cytostasis by a given
activated cell population (Gorczynski &
MacRae, 1981). These data suggested that
our cytostasis assay may enable us to
determine:
(i) the events in the lymphoid hierarchy
of the host which may encourage the
development ofsecondary tumour growth,
and
(ii) the cells within a given tumour
which have a potential for metastasis.
Both of these questions have been
approached in the experiments described
below, by correlation of a series of
analyses on 4 independent assays per-IN VITRO AND IN VIVO CONTROL OF TUMOUR-CELL GROWTH
formed with either a standard tumour-cell
population and a variety of effector cells,
or the converse. Three of these assays, in
vitro cytotoxicity and cytostasis assays,
and in vivo growth modulation of s.c.
implants of tumour cells, have been
described in detail elsewhere (Gorczynski,
1978; Gorezynski & MacRae, unpub. and
1981). The 4th assay, lung colony growth
after i.v. inoculation of tumour cells into
irradiated mice, is documented below. The
data support the notion that the events
associated with the regulation of cellular
cytostasis for embryo-antigen-bearing tar-
get cells in vitro are important predictors
of tumour spread in vivo.
MATERIALS AND METHODS
Mice.-C3H/HeJ mice were obtained from
the Jackson Laboratories, Bar Harbor,
Maine. All mice were kept 5 to a cage and
allowed food and water ad libitum.
Tumours.-Retired breeder mice from
Jackson Laboratories were inspected twice
weekly for the appearance of spontaneous
tumours. All data reported below were
obtained with experiments using cells from
one such transplantable tumour, adeno29, a
mammary adenocarcinoma (Department of
Histology/Pathology, Princess Margaret Hos-
pital). However, it is important to note that,
without exception, similar results have been
obtained using other such spontaneously
appearing tumours (adenoll, adeno32,
adeno36)-
Neoplasms were disaggregated with a
mixture of 2-5% trypsin solution (Grand
Island Biologicals, New York), crude col-
lagenase (CLS II, 14 u/mg; Worthington
Biochemicals, Freehold, New Jersey) and
deoxyribonuclease (DNase I, B grade, 7 x 104
Dornase u/mg; Calbiochem, San Diego,
California). All enzymes were used at a con-
centration of 041 jg/ml, and the tumour cells
were harvested from the digestion flask for
90 min (at 30-min intervals). The yield from
the initial primary adeno29 tumour was
15 x 107 cells (Gorezynski, 1978; Russell et
al., 1976). 14 x 107 cells were frozen at -70°C
in x-MEM containing dimethyl sulphoxide
(DMSO) (15%) and foetal calf serum (30%)
in aliquots of 3x 106 cells (concentration
1-5 x 106/ml). All experiments reported below
used as starting material the cells prepared
from an s.c. tumour produced in normal
(8-week) female mice upon transplantation of
2 x 106 cells recovered from this frozen stock
(mean recovery ofviable cells on thawing was
40 + 10%)-the tumour grew to a mean
volume of 1-8 cm3 (±0 3 cm3) after 20 days
oftransplantation of "thawed" primary cells.
Tumour resection was performed under
ether anaesthesia as described in individual
experiments. Tumour volume was measured
with calipers, the volume being assessed by
the formula: volume=04ab2 where a is the
maximum dimension of the tumour and b is
the diameter at right angles to a (Attia et al.,
1965).
Preparation ofembryofibroblasts, spleen cells
and techniques of velocity sedimentation and
cell culture. These procedures were per-
formed as described elsewhere (Gorezynski,
1978).
Microcytotoxicity and cytostasis assays
(Gorczynski, 1978; Gorczynski & MacRae,
1981).-In brief, 2 x 103 embryo fibroblast
target cells (either pre-labelled with 3H-
proline for cytotoxicity assay, or post-
labelled at 48 h with [3H]-dT for cytostasis
assay) were dispersed in 100 ,ul into wells of
a 96-well Linbro microtitre plate. After
allowing 3 h for the target cells to adhere,
effector cells were added in a final volume of
200 ,ul at different concentrations to the well.
All groups of varying effector:target ratios
were set up in triplicate. Control groups con-
tained only medium added to the targets
(spontaneous cytotoxicity/cytostasis) or
water (total releasable ct/min-cytotoxicity:
maximum growth inhibition-cytostasis). At
48 h plates in the cytotoxicity assay were
centrifuged at 500 g for 5 min at 4°C; 100 ,ld
ofthe supernatant in each well was dissolved
in 5 ml Aquasol (New England Nuclear,
Boston, Mass.) and the samples counted in a
well-type scintillation counter. Percent
specific cytotoxicity was measured as:
ct/min experimental-
100 x . ct/min spontaneous ct/mmn H20 -ct/min spontaneous
At 48 h wells in the plates used for the
cytostasis assay were washed x3 with
sterile warm PBS, and 200 ,ul of [3H]-dT in
a-MEM medium with 10% foetal calf serum
(aF1o) (0 5 MCi/well) was added per well. The
plates were returned to a humidified C02
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incubator for 8 h when the wells were washed
thoroughly and air-dried. The contents in
each well were dissolved in I-OM NaOH,
transferred to scintillation vials, neutralized
with 1-OM HCR, dissolved in 5 ml Aquasol and
counted as above. Percent specific cytostasis
was calculated as:
ct/min spontaneous-
100 x . ct/min experimental ct/mmn spontaneous -ct/min H20
As described elsewhere, this is an accurate
reflection of cytostatic activity only in the
absence of cytotoxicity from the population
under test (Gorczynski & MacRae, 1981).
In vivo assayfor anti-tumour effector cells.-
An in vivo assay which detects cells able to
regulate s.c. growth ofimplanted tumour cells
is described elsewhere (Gorczynski & MacRae,
unpublished). In brief, mice were lethally
irradiated (9 5 Gy) and transplanted i.v. with
5x 106 syngeneic marrow cells. Putative
effector cells were also transferred i.v. at this
time. Seven days after irradiation all mice
were inoculated s.c. with 106 tumour cells in
0-15 ml PBS. Tumour volume was measured
3 times a week after the tumour became
palpable.
Recipient mice were irradiated (6 Gy) 6 h
before i.v. tumour-cell inoculation, and re-
ceived putative effector cells 2 h after
irradiation. The animals were killed 21-24
days afterirradiation, whichgenerallymarked
the first evidence for respiratory distress. The
lungs were removed and placed into Bouin's
solution, and lung colonies counted macro-
scopically. At least 4 mice were used per
group.
Statistical analysis.-Statistical comparison
of experimentally determined parameters for
different groups of animals (or cell popula-
tions derived from them) were performed
using a non-parametric Mann-Whitney test
(Freund, 1962).
RESULTS
Quantitation of inhibition of growth of
tumour lung nodules as a function of
effector cells transferred
In a series of earlier studies we have
developed quantitative long-term (48h)
assays in vitro by which cytotoxicity or
cytostasis of an effector population for
target cells bearing embryo-associated
antigenic determinants can be measured
(Gorczynski, 1978; Gorczynski & MacRae,
1981). Furthermore, we have shown that
similar quantitative analysis can be used
to assess the regulation of growth of s.c.
tumour-cell implants by different effector-
cell populations (Gorczynski & MacRae,
unpublished). Effector cells in cytostasis
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FiG. I. Tumour-cell dose-response curve
for lung colonies after i.v. inoculation of
tumour cells (a) and effect ofactivated peri-
toneal-exudate cells on lung-colony forma-
tion (b). All mice given tumour cells
(adeno29) i.v. were pretreated with 6 Gy
whole-body irradiation 2 h before inocula-
tion.
(a) Tumour cells were given alone
(in 0 5 ml PBS, x ) or with 2 x 107 irradiated
(20 Gy) normal spleen cells as an inert
carrier population (0). Five mice were
used per group and lung colonies were
counted macroscopically 25 days later.
(b) All mice received 3 x 105 tumour
cells (mixed with 2 x 107 irradiated carrier
spleen cells) along with varying numbers
of peritoneal-exudate cells harvested from
mice given 0-3 ml complete Freund's
adjuvant 2 days earlier ( x ). The peri-
toneal-exudate cells were also tested in
triplicate at different dilutions for their
ability to cause cytostasis of 2 x 103
14-day C3H embryo fibioblast target cells in
a standard in vitro assay (0). All points
represent arithmetic means + s.e.
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and cytotoxicity assays were not identical
cell populations. In the absence ofa highly
metastatic spontaneous adenocarcinoma,
we have resorted to another means of
studying the regulation of growth of
tumour cells which escape into the
systemic circulation, by deliberately trans-
ferring different i.v. doses of tumour cells
(3x 10 or 3 x 105) in 0 5 ml PBS to groups
of 5 sublethally irradiated (6 Gy) recipi-
ents Fig. 1(a). An inert "carrier" cell
population (20 Gy syngeneic normal spleen
cells, 2 x 107 per recipient) was included
in some recipients (@-*, compare with
x - x, no carrier cells) to study whether
"seeding" of tumour cells to the lung was
more effective at the various tumour-cell
dilutions in the presence of such a carrier
(Hill & Stanley, 1975). The data of this
panel (a) of Fig. 1 indicate that, in the
presence ofan inert carrier-cell population,
the number of tumour lung nodules
counted macroscopically at Day 25 after
transfer of tumour cells was a function of
the number of tumour cells inoculated.
Similar results were obtained in 3 repeat
experiments (data not shown).
When peritoneal-exudate cells were
taken from mice 48 h after i.p. inoculation
of 0 3 ml complete Freund's adjuvant,
and examined for their ability to affect
tumour lung colony growth or cause cyto-
FIG. 2. Comparison of in vttro and in vivo
assays of anti-tumour and anti-embryo
effector-cell activity using spleen lympho-
cytesobtainedfrom 5-daycultures ofnormaI
C3H/HeJ female cells. Spleen cells har-
vested from cultures initially containing
5 x 108 cells were sedimented for 4 h at
4°C. The fractions shown were harvested
and assayed (along with an unfractionated
control sample at extreme left) for activity
at various dilutions in cytotoxicity (a) and
cytostasis (b) tests with 14-day-old C3H
embryo fibroblast targets or in vivo for
inhibition of growth of s.c. (c) and i.v. (d)
transplanted cells from a spontaneously
appearing tumour, adeno29. Data from the
in vitro tests are for an equivalent effector:
target ratio for unfractionated cells of
23:1; for in vivo assays the data points rep-
resent an equivalent effector:target ratio
for unfractionated cells of 25:1 (s.c.) or 8:1
(i.v.). All values shown represent the arith-
metic mean of 3 cultures per point, or 5
mice per group (in vivo assay).
stasis ofembryo fibroblast targets in vitro,
the data ofFig. 1(b) were obtained. As can
be seen irom this Figure, cells with cvto-
static activity (@-*) exert appreciable
inhibition of lung colony formation when
given i.v. along with tumour cells. In two
repeat experiments in which we inoculated
this large tumour-cell dose (3-5x 105)
without carrier cells, we again found a
quantitative inhibition of colony forma-
tion by activated peritoneal-exudate cells
(data not shown). Thus, unless the experi-
mental protocol involved variations in the
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dose of tumour cells in the inocula,
irradiated spleen carrier cells were omitted
from the experiments described below.
Correlation between in vitro and in vivo
assays for detecting effector cells regulating
the growth of cells with embryo-associated
antigenic determinants
We have described both in vitro (cyto-
toxicity and cytostasis) and in vivo (regu-
lation of growth of s.c. tumour implants;
inhibition of lung colony growth after i.v.
inoculation) assays which detect effector
cells expressing activity against spon-
taneously appearing adenocarcinoma tar-
get cells. Spleen lymphoid cells precultured
for 5 days are known to express activity in
the first 3 assays mentioned, though the
in vitro cytotoxicity assay was found to be
better correlated with regulation ofgrowth
of s.c. tumour implants than the cyto-
stasis assay (Gorczynski & MacRae, uin-
published). In order to assess the ability
of cultured spleen cells to affect tumour-
cell growth as lung colonies, we cultured
5 x 108 female spleen lymphoid cells in
Falcon culture flasks (75 cm2 growth area;
108 cells per flask in 100 ml oxFlo). After 5
days the cells recovered from the flasks
(2 x 108) were pooled, washed (1000 rev/
min for 5 min at 4°C) and resuspended in
35 ml 0.3%O BSA in PBS. Thirty ml of the
cells were sedimented for 4 h at 4°C over
a gradient ranging from 0.6% BSA to 2%
BSA in PBS, and cells differing in sedi-
mentation velocity by 1 mm/h were
collected. The various fractions and an
unfractionated control sample were tested
at various dilutions (005oo, 0.15% and
0.5% of the cells per fraction) in triplicate
in vitro, using 2 x 103 14-day-old C3H
embryo fibroblast cells/well in Linbro
microtest wells. Target cells were pre-
labelled with 3H-proline or post-labelled
with [3H]-dT according to whether cyto
toxicity or cytostasis assays were to be
performed. Data shown in Fig. 2 represent
cytotoxicity and cytostasis for 0.15% of
the cells/fraction (representing an un-
fractionated effector:target of 23: 1).
In addition to these in vitro assays, 8%
ofthe cells ofeach fraction (an unfraction-
ated equivalent of 2-5 x 106 cells) was
injected i.v. into 2 groups of 5 per group
C3H/HeJ female mice, either given 6 Gy
or 9-5 Gy and 5 x 106 syngeneic marrow
cells 2 h earlier. The group of 5 mice
receiving 6 Gy were given 3 x 105 tumour
cells i.v. 6 h after spleen-cell transfer, the
other group receiving 106 tumour cells s.c.
7 days later. All tumour cells used were
from a spontaneously appearing adeno-
carcinoma (adeno29). Lung colonies were
examined in the former groups at 21 days,
and tumour growth in the latter groups
measured with calipers every 3 days after
the appearance of palpable tumour. The
data for one experiment (of 3) ofthis type
are shown in Fig. 2 (tumour volumes for
these groups were assessed at Day 38).
Visual inspection of these data, coupled
with statistical analysis of the coefficient
of correlation for the activity profiles
represented by individual panels (see
Table I) provides evidence that whilst
activity in an in vitro cytotoxicity test is
better correlated with inhibition of local
s.c. growth of tumours than appearance
of lung nodules after i.v. injection of
tumour cells (r=0.90 vs r=0.57) assays
for cytostatic activity appear to detect
preferentially those cells capable of regu-
lating an i.v. challenge of tumour cells
(r=0.99) rather than those regulating an
TABLE I.-Analysis of correlation coefficients (± s.e.) of sedimentationpr9files shown in
Fig. 2
Assay performed-+
00 cytotoxicity
00 cytostasis
Tumour volume
(s.c. growth)
o/ i0 cytostasis
-0-63+0-15
Tumour vol. No. of lung
(s.c. growth) colonies
-0 90+0-16 0 57+0-14
0-44+0 14 -0 99+0-21
0-39 + 0-12
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s.c. challenge of cells (r=0.44). Similar
data were obtained in the repeat experi-
ments.
Comparison of in vivo activity (on lung
colony formation) of splenic cytostatic
effector cells derivedfrom tumour-inoculated
mice at different times after tumour induc-
tion/resection
In an earlier report, we showed that
sedimented spleen cells of mice exposed
in vivo to embryo-associated antigens
(either during pregnancy or during growth
of tumours bearing embryo-associated
antigen determinants) werenaturally cyto-
static for embryo-fibroblast target cells in
vitro (Gorezynski & MacRae, 1981). The
kinetics ofdevelopment ofoverall effector-
cell activity in spleen cells of pregnant
animals was consistent with the idea of
the early production of both a fast-
sedimenting and a slow-sedimenting cyto-
static effector-cell progenitor (e.g. as in
Fig. 2) with late activity residing mainly
in a slow-sedimenting (memory?) cell
population. In mice inoculated with
tumour cells the early activity did indeed
appear in two physically distinct cell
populations, but mice analysed later after
tumour resection, provided little evidence
FIG. 3.- Comparison of cytostatic effector-
cell activity in vitro (a) and ability to
decrease tumour lung colonies after i.v.
tumour-cell inoculation (b) using velocity-
sedimented spleen cells taken from donor
mice at different times after tumoui
inoculation (TB) and resection (R). Groups
of 10 mice were inoculated with adeno29
cells at 20-day inteivals, the tumour being
resected some 22 days later. Spleen cells
were harvested from the mice at 100 days,
sedimented at I g for 3 h, and the two
effector pools shown tested in vitro and in
vivo at a 30:1 (effector:target) for cytostasis
to 14-day-old embryo fibroblast targets,
or inhibition of lung-colony growth in
secondary 6Gy recipients given 3 x 105
adeno29 cells i.v. All data shown represent
arithmetic means (± s.e.) of 5 mice/group or
3 cultures/point. * in (b) indicates lung
colony growth in recipient mice given no
additional spleen effector cells.
(c) indicates lungcolonygrowthinanimals
equivalent to the primary spleen-cell
donors (a, b) as 6Gy recipients of 3 x 105
adeno29 cells. Each point represents the
arithmetic mean for 5 mice.
for cytostatic effector-cell activity, in
either slow- or fast-sedimenting cells. If
this decline of cytostatic effector-cell
activity were an indication that these
hosts might now be "conditioned" for the
development of secondary disease, we
predicted that: (i) sedimented spleen cells
from these animals would have little or no
activity on adoptive transfer in affecting
lung colony growth in syngeneic recipi-
ents, and (ii) these "late-resected" mice
would be particularly suitable hosts for
growth of i.v. inoculated tumour cells.
Data from such an analysis are shown in
Fig. 3. For this experiment groups of 10
mice, each from an initial batch of 60 age-
matched females, were inoculated s.c.
with 106 adeno29 cells at intervals of 20
days. When the tumour was palpable
(_1 cm3) the tumour was removed under
ether anaesthesia (generally some 22 days
from transplant). At 100 days, 5 mice from
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each group were killed for use as spleen-
cell donors. Five x 108 spleen cells ofeach
pool were sedimented for 3 h at 4°C, and
the populations of cells sedimenting in the
regions 2*5-4'5 or 6-9 mni/h collected as
previously determined. Each population of
cells was resuspended to a concentration of
107 cells/mlandassayedintriplicateatvari-
ous dilutions (105, 3 x 104, 104 and 3 x 103
cells/well) for cytostasis to 103 14-day-old
C3H embryo fibroblast target cells (Fig.
3a). In addition, 9 x 106 cells ofeach popu-
lation were inoculated i.v. into groups of
5 normal age-matched females, pretreated
2 h before with 6 Gy and subsequently
given 3 x 105 adeno29 cells i.v.; a control
group of mice received only irradiation
and tumour cells (0 in Fig. 3b). Finally,
the remaining 5 mice of each of the initial
tumour inoculated mice were given 6 Gy
followed within 2 h by 3 x 105 adeno29
cells i.v. (Fig. 3c). All mice were killed and
examined macroscopically for tumour lung
colonies on Day 23 after i.v. transplanta-
tion oftumour cells.
The data of Fig. 3 are representative of
the results obtained for this study, which
has been repeated in toto on two separate
occasions. It is clear from these data (left-
hand panel a, b) that fast-sedimenting
cells from tumour-bearing mice, or from
mice 20 and 40 days after tumour resec-
tion, have appreciable cytostatic activity
in vitro and a pronounced capacity to
inhibit lung colony growth of i.v. injected
tumour cells. However, at 80 days after
tumour resection, both in vitro cytostasis
and in vivo activity are markedly dimin-
ished. These effects are even more pro-
nounced when slow-sedimenting effector
cells are investigated (Fig. 3a,b right-hand
panel), though now interestingly even
tumour-bearer spleen cells were relatively
inactive in each assay. Most dramatically,
when the donors of the spleen cells used
in in vitro cytotoxic or in vivo lung colony
assays (a, b) were themselves used as
recipients of i.v. tumour cells (c) the
numbers oflung colonies detected in these
groups ofmice were highly correlated with
the activity of small and large splenic
effector cells in the assays ofcytostasis and
growth of lung colonies. (Large cells for
cytostatic and lung colony assays r=
0 85 + 0-17) 0'84 + 0 25 respectively; small
cells for cytostatic and lung colony assays,
r= 0*79 + 014, 0485 + 016 respectively.)
Note here and throughout the paper
that these correlation coefficients are
derived from statistical treatment of data
from individual animals, whilst the data
shown in the Figure "pre-group" these
data, and show only the arithmetic means
of the discrete groups.
Differential susceptibility of populations of
cells from a solid tumour m8ss to cytostasis
by effector cells in vitro and lung-colony
growth regulation in vivo
Earlier studies suggested that cells
isolated by enzymatic digestion from
within a growing solid tumour, and subse-
quently separated into discrete subpopu-
lations by velocity sedimentation, were
highly heterogeneous in theirsusceptibility
to the cytostatic activity of different cell
populations (Gorczynski & MacRae,
1980b). Ifthese differences reported earlier
are truly reflective of heterogeneity in
tumour cells of a given solid tumour,
separation of tumour cells by velocity
sedimentation should reveal this hetero-
geneity of the tumour cells.
A group of 4 mice were inoculated s.c.
with 2 x 106 adeno29 cells in 0 I ml PBS.
When the tumour mass was - 1-5 cm3 in
all recipients (range 2 3-1 0 cm3) all mice
were killed, the tumours pooled, and an
enzymatic digest of the tumour was pre-
pared. Five x 107 cells were separated for
2 h at 4°C, and the fractions shown in
Fig. 4 collected (differing in sedimentation
velocity by 2 mm/h). Data to the left ofall
panels show unfractionated cells. All cells
were washed and resuspended to a con-
centration of 106/ml. Three x 105 cells of
each fraction were then injected i.v. into
each of 8 (6 Gy) recipient mice or 5 x 104
cells were cultured in 6 replicate wells of
Linbro microtest plates. To 3 wells ofeach
group in the plate (Fig. 4a) or 4 mice of
each in vivo group (Fig. 4c) was added
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FIG. 4.-Cytostasis and lung colony growth
using fractionated tumour cells (from asolid
tumour mass) as a source ofdifferent target-
cell populations (see text for details).
Tumour cells prepared from adeno29 were
sedimented and the fractions shown tested
in vitro (a) or in vivo (c) for their ability
to incorporate 3H-thymidine or produce
lung colonies in the presence of a 30-fold
excess ofperitoneal-exudate cells from mice
given 0 3 ml complete Freund's adjuvant 2
days earlier. (b) Lung colonies produced
by different fractions in the absence of
added peritoneal-exudate cells. Points to
the left of each panel show data from
unfractionated tumour cells. All values
shown are arithmetic means (± s.e.) of
3 cultures/point (a) or 4 mice per group (b),
(c).
1-5 x 106 or 10 x 106 (respectively) peri-
toneal-exudate cells from a pool of 8 mice
given 0-3 ml complete Freund's adjuvant
2 days earlier. The cytostatic plates were
harvested at 48 h, and lung colonies
counted in all mice at 24 days.
Inspection of Fig. 4(b) (data from one of
two experiments) shows that all fractions
of tumour cells were capable of growing
into colonies in the lungs of these sub-
lethally irradiated recipients. We have
already similarly reported that all such
fractions can grow as s.c. implants, and
that there was a good correlation between
[3H]-dT uptake in culture (control wells
for Panel a) and s.c. tumour growth in
vivo (Gorczynski & MacRae, 1981). Most
interestingly, whilst there is little variation
in the ability of the different populations
of tumour cells to grow unopposed in vivo
(Panel b), when effector cells were added
in vitro (Panel a) or in vivo (Panel c)
marked heterogeneity of tumour cells was
apparent. The cells most susceptible to
cytostasis in vitro (sedimentation velocity
5-10 mm/h) grow less well in vivo and vice
versa (correlation coefficientfortheactivity
profiles documented in Panels (a) and (c)
is 0.93+ 0.13).
Analysis of in vivo lung colony growth and
in vitro cytostasis using different tumour-
cell populations prepared from a solid
tumour, and cytostatic effector cells prepared
from tumour-inoculated animals at various
stages oftuMour growth
The data shown in Fig. 3 presented a
case for a possible role of cytostatic
effector cells present in tumour-bearer
mice and in mice shortly after tumour
resection (e.g. 20 days) in controlling lung
colony formation as assessed by autolo-
gous, adoptively transferred tumour cells
in secondary hosts. The data presented
above (Fig. 4) in turn have suggested that
within a solid tumour mass there are
tumorigenic cells which are unresponsive
in vitro to cytostatic effector cells. These
cells are notably capable of resisting the
inhibitory effect upon lung colony forma-
tion in an adoptive-transfer assay of a
deliberately induced cytostatic effector
population. These experiments collectively
suggest that subpopulations of cells within
a given solid tumour will show different
patterns of susceptibility to cytostasis in
vitro and lung colony growth (after i.v.
(c)
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FiG. 5.-Cytostasis and lung colony growth
using fractionated tumour cells from a solid
tumour mass as a source of "independent"
cell subpopulations, and effector cells
isolated from velocity-sedimented spleen
lymphocytes of tumour-bearer (0) or
tumour-resected (40 days earlier, 0) mice.
Tumour cells prepared from a pool of 4
mice bearing s.c. growth of adeno29 were
disaggregated, sedimented at 1 g, and tested
in vitro (a) for their ability to incorporate
[3H]-dT in the presence and absence of
velocity-sedimented spleen effector cells
from the same individuals (0-0) or from
mice the adeno29 tumours of which had
been surgically removed 40 days earlier
(0-0). Per cent specific cytostasis of the
different tumour-cell subpopulations is
shown at an effector: target of 20:1. In
addition, 3 x 105 tumour cells of each frac-
tion was inoculated i.v. into groups of 4
sublethally irradiated (6 Gy) mice, with and
without the effector cells described (b); the
effector: target ratios was 20: 1. Lung
colonies in all groups were counted macro-
scopically at Day 24. Points x indicate the
colony growth in mice given no effector
spleen cells. All points show arithmetic
mean (±s.e.), and data to the left of each
panel indicate cytostasis/lung colony
growth with unfractionated tumour cells.
transfer) in vivo. Furthermore, effector
cells from spleen lymphocytes of mice at
different stages of tumour growth should
allow us to demonstrate the different
susceptibilities, using either an in vitro
cytostasis assay or in vivo lung colony
formation.
Five mice were inoculated s.c. with
2 x 106 adeno29 cells. When the tumour
volume was 1-5 cm3 the tumour was
excised (Day 21). Twenty days later a
further 4 mice were inoculated s.c. with
2 x 106 adeno29 cells. At 19 days all
animals were killed and the tumour cells
and spleen cells pooled within equivalent
groups. The 3 pools of cells (tumour,
tumour-bearer spleen, 40-day-resected
spleen) were sedimented at unit gravity to
obtain cell fractions equivalent to those
described in Figs 3 and 4. All tumour cells
were resuspended at 106 cells/ml, and
3 x 105 cells injected into each of 20
recipient mice (pretreated with 6 Gy of
ionizing radiation). Fivex 104 cells of
each tumour-cell population were cultured
in 6 replicate wells of Linbro microtest
plates. Effector cells used in vivo were
6 x 106 cells from slow- or fast-sedimenting
spleen cells of the two original donor
pools; the effector cells used in vitro were
106 cells of the same pools (in both cases,
therefore, the effector:target ratio was
20:1). Control groups in vivo and in vitro
received no effector cells. In vitro cyto-
stasis was assessed at 48 h, and lung
colony growth at 24 days (see Fig. 5).
Analysisofthe curves shown as (O -0),
(0-0) in the right- and left-hand panels
of this figure re-emphasizes the point
made initially in Fig. 3, namely that whilst
fast-sedimenting effector cells of both
tumour-bearer and 40-day-resected spleen
donors can produce cytostasis and lung
colony growth inhibition, the slow-sedi-
menting effector cells in tumour-bearer
animals are singularly incapable of either.
However, inspection of the data in terms
of heterogeneity of tumour cells is equally
revealing. It is apparent that the different
activity of spleen cells from tumour-
bearers and tumour-resected individuals
is most pronounced with slow-sedimenting
(< 15 mm/h) tumour cells. When large
tumour cells are investigated (see also
Fig. 4) a marked resistance to cytostasis
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TABLE II.-Analysis of correlation co-
efficients for activity measured in Fig. 5,
in vivo or in vitro with different effector
cells
Peak
sedimentation
velocity of
effector cells
Source of
spleen cells
6-9 mm/h Tumour bearer
Tumour resected
2-5-4-5 mm/li Tumour bearer
Tumour iesected
r + s.e.
0-72+0 16
0-96 + 0-21
0-96+ 0-14
0-84 + 0-18
or regulation of lung colony growth is
apparent, irrespective of the source of
effector cells. Once again, a high correla-
tion between activity in the 2 different
assays was observed with all effector cells
studied (Table II). Similar data to those
shown here were obtainedwhen the experi-
ment was repeated, in particular the differ-
ent biological activity ofslow-sedimenting
effector cells in tumour-bearer andtumour-
resected donors, and the different sus-
ceptibility (to cytostasis or lung colony
growth (of slow- or fast-sedimenting
tumour cells.
DISCUSSION
A variety of assays have been described
by which immune reactivity of a host can
be demonstrated for antigens expressed by
autologous tumour cells. In order to assess
whether these assays are a measure of
functions which may be of prognostic
value, experimental studies in animal
model systems are essential. Using a
model system in which we investigated
the growth of a subcutaneous tumour
implant (from an initially spontaneous
tumour) and its regulation by cells
deliberately exposed in vitro or in vivo to
embryo-associated antigens, we concluded
that an in vitro analysis of cytotoxic
effector cells (for suitably labelled embryo
fibroblast targets) allowed us to predict
which effector-cell populations would be
active in controlling s.c. growth of the
tumour (Gorczynski & MacRae, 1980a).
However, when tumour cells were
allowed to seed to the lung of recipient
mice (after i.v. transfer), the cytotoxic
potential of a given effector-cell pool was
found to give a poor reflection of its
capacity to modulate tumour lung colonies (Fig. 2). In contrast, an assay
measuring the cytostatic capacity of the
effector-cell preparation was able to pre- dict the in vivo efficiency of the effector
cells in regulating lung-colony function in
vivo (Fig. 2). This is consistent with our
own and other workers' earlier observa-
tions that: (i) cytotoxic effector cells are
predominantly lymphocytic in origin (Gorczinski, 1976) in contrast to those
cells which exert cytostasis in vitro
(lymphocyte and non-lymphocyte cell
pools) (Gorczynski & MacRae, 1981;
Owen & Seeger, 1973), and (ii) the degree of non-lymphocyte (macrophage) infiltra-
tion of solid tumours reflects the meta-
static potential ofthetumour, and tumour
metastasis itself may be experimentally
controlled by transfer of activated macro-
phages (see also Fig. 1) (Hibbs, 1973; Eccles & Alexander, 1974; Fidler, 1974). Indeed, recent data by Fidler (1980) sug- gest that mice inoculated s.c. with spon- taneously metastasizing melanomas can
be maintained free of metastases by inoculation ofliposomes containing macro-
phage-activating factors (lymphokines) after surgery, whereas control mice (sur-
gery and control liposomes only) rapidly succumbed to metastatic growth. Two other features which may be
important in vivo in the natural process of
tumour spread have been studied. In an
earlier report we indicated that cytostatic effector activity induced during growth of
syngeneic transplantable tumour cells
diminished with time after tumour re-
section, and unlike the similar activity
appearing after natural exposure to em-
bryonic antigens during pregnancy, appeared to lack a "memory cell" com-
partment (Gorczynski & MacRae, 1981). We suggested that this in turn might be
reflected in a diminished ability oflymph- oid cells from such animals to control
distal spread of tumour cells, a possi- bility which was further explored in the
experiment described in Fig. 3. Using an
4142 R. M. GORCZYNSKI AND S. MACRAE
alternative system to examine regulation
of systemic tumour growth, we did find
that long after tumour resection (80 days)
spleen lymphocytes from these donors
were unable to produce a decrease in
growth of adoptively transferred tumour
cells, and in fact these recipients (used as
hosts for the tumour) supported a greater
lung-colony growth than normal animals
(see Fig. 3). It should be noted as a point
of reservation to this last analysis, that
while control groups (tumour resected,
irradiated, no i.v. tumour cells) did not
contain lung colonies on the day of assay,
one interpretation of the data that is not
yet conclusively overruled is that addi-
tional i.v. tumour cells enhanced the
subsequent growth of latent colonies in
these recipients.
There is abundant experimental evi-
dence for the notion that tumours are
heterogenous for a variety of phenotypic
characteristics, of which metastatic
potential is but one (Poste & Fidler, 1980).
In line with these studies, we have shown
that the heterogeneity (in terms of in
vitro susceptibility to cytostasis by a given
pool of effector cells) of subpopulations of
cells isolated from a given solid tumour
mass is apparent in the inhibition of lung
colony growth by effector cells. A strong
correlation existed between those cells
susceptible to cytostasis in vitro and to
growth inhibition of lung colonies in vivo
(Fig. 4). In an experiment which syn-
thesized the findings of Figs 3 and 4, we
showed that this heterogeneity (differen-
tial susceptibility to growth regulation in
vitro and in vivo) of tumour cells can be
demonstrated using as an effector-cell
source cytostatic effector cells from
tumour-stimulated animals (Fig. 5). These
findings suggest that an explanation for
tumour metastasis is two-fold:
(1) a decline in cytostatic (regulator)
effector cells withinthe tumour bearer, and
(2) the appearance of tumour cells re-
fractory to their activity.
If these tumour cells are genuinely re-
fractory to cytostatic effector cells, the
phenomenon we have described may per-
haps be distinct from that of Kerbel
(1979), who reported the unsuccessful
attempt to select for tumour cells resistant
to macrophage cytotoxicity in vitro,
despite successful selection of cells resist-
ant to other toxic regimes. However, with
the growing body ofdata suggesting a role
for a non-macrophage, natural killer (NK)
cell which is capable of causing spon-
taneous cell-mediated cytotoxicity to
tumour cells in species including man and
mice (Herberman & Holden, 1978) and is
implicated in immune surveillance and
tumour immunity (Haller et al., 1977) it
is perhaps unwise to speculate, in the
absence ofconcrete evidence, on the actual
nature ofthe effector cellinvestigatedhere.
Indeed, the decline in activity may be
more apparent than real (e.g. see in vitro
and in vivo activity measured from slow-
sedimenting spleen cells of tumour-
resected animals with tumour cells sedi-
menting at 7-12 mm/h in Fig. 5). The
diminished activity we measured may
reflect the ability of fast-sedimenting
tumour cells to induce cells (suppressors)
which counteract the activity of cyto-
static effector cells (e.g. 0-0 for tumour
cells sedimenting in the region 15-20
mm/h in the lower right panel of Fig. 5
indicates greater lung nodule formation
than in control mice ( x - x ) given tumour
cells alone). A role for suppressor cells
capable of neutralizing the activity of
cytotoxic effector cells in the regulation of
local s.c. growth of tumour cells has been
described by us (Gorezynski & MacRae,
unpublished). Future studies will require
an assessment of the correlation between
these findings and the general phenomenon
of promotion of lung-colony formation
reported here.
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